Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia

A comparison with lovastatin

Ansarullah, R. Jadeja, Menaka Thounaojam, V. Patel, R. Devkar, A. Ramachandran

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We investigated the antihyperlipidemic activity of an aqueous extract of a herbal preparation from a combination of six Indian medicinal plants. The current study was undertaken to assess the hypolipidemic, hypocholesterolemic and hypotriglyceridemic potential of the polyherbal extract using Triton WR 1339 (Tyloxapol) induced hyperlipidemia. The animals were divided into four groups'normal control, hyperlipidemic control, hyperlipidemic plus polyherbal extract and hyperlipidemic plus Lovastatin. Hyperlipidemia was induced by single intravenous injection of Triton WR 1339. Intragastric administration of polyherbal extract (500mg/kg of body weight) significantly decreased plasma cholesterol, triglyceride, non-HDL-C and phospholipids levels and increased HDL-C levels. Atherogenic index and triglyceride secretion rate were lowered in the polyherbal extract fed animals when compared to hyperlipidemic animals. Polyherbal extract exhibited quite competitive potential when compared with the reference drug Lovastatin affording a possible alternative therapeutic agent in the treatment of hyperlipidemia.

Original languageEnglish (US)
Pages (from-to)119-124
Number of pages6
JournalInternational Journal of Green Pharmacy
Volume3
Issue number2
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Hypolipidemic Agents
Lovastatin
Hyperlipidemias
Triglycerides
Plant Preparations
Medicinal Plants
Intravenous Injections
Phospholipids
Cholesterol
Body Weight
Control Groups
Therapeutics
Pharmaceutical Preparations
tyloxapol

Keywords

  • Hypercholesterolemia
  • Polyherbal
  • Triton WR 1339

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia : A comparison with lovastatin. / Ansarullah; Jadeja, R.; Thounaojam, Menaka; Patel, V.; Devkar, R.; Ramachandran, A.

In: International Journal of Green Pharmacy, Vol. 3, No. 2, 01.04.2009, p. 119-124.

Research output: Contribution to journalArticle

@article{cfce1216665048d1b0f55ec6e3dca60f,
title = "Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia: A comparison with lovastatin",
abstract = "We investigated the antihyperlipidemic activity of an aqueous extract of a herbal preparation from a combination of six Indian medicinal plants. The current study was undertaken to assess the hypolipidemic, hypocholesterolemic and hypotriglyceridemic potential of the polyherbal extract using Triton WR 1339 (Tyloxapol) induced hyperlipidemia. The animals were divided into four groups'normal control, hyperlipidemic control, hyperlipidemic plus polyherbal extract and hyperlipidemic plus Lovastatin. Hyperlipidemia was induced by single intravenous injection of Triton WR 1339. Intragastric administration of polyherbal extract (500mg/kg of body weight) significantly decreased plasma cholesterol, triglyceride, non-HDL-C and phospholipids levels and increased HDL-C levels. Atherogenic index and triglyceride secretion rate were lowered in the polyherbal extract fed animals when compared to hyperlipidemic animals. Polyherbal extract exhibited quite competitive potential when compared with the reference drug Lovastatin affording a possible alternative therapeutic agent in the treatment of hyperlipidemia.",
keywords = "Hypercholesterolemia, Polyherbal, Triton WR 1339",
author = "Ansarullah and R. Jadeja and Menaka Thounaojam and V. Patel and R. Devkar and A. Ramachandran",
year = "2009",
month = "4",
day = "1",
doi = "10.4103/0973-8258.54900",
language = "English (US)",
volume = "3",
pages = "119--124",
journal = "International Journal of Green Pharmacy",
issn = "0973-8258",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia

T2 - A comparison with lovastatin

AU - Ansarullah,

AU - Jadeja, R.

AU - Thounaojam, Menaka

AU - Patel, V.

AU - Devkar, R.

AU - Ramachandran, A.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - We investigated the antihyperlipidemic activity of an aqueous extract of a herbal preparation from a combination of six Indian medicinal plants. The current study was undertaken to assess the hypolipidemic, hypocholesterolemic and hypotriglyceridemic potential of the polyherbal extract using Triton WR 1339 (Tyloxapol) induced hyperlipidemia. The animals were divided into four groups'normal control, hyperlipidemic control, hyperlipidemic plus polyherbal extract and hyperlipidemic plus Lovastatin. Hyperlipidemia was induced by single intravenous injection of Triton WR 1339. Intragastric administration of polyherbal extract (500mg/kg of body weight) significantly decreased plasma cholesterol, triglyceride, non-HDL-C and phospholipids levels and increased HDL-C levels. Atherogenic index and triglyceride secretion rate were lowered in the polyherbal extract fed animals when compared to hyperlipidemic animals. Polyherbal extract exhibited quite competitive potential when compared with the reference drug Lovastatin affording a possible alternative therapeutic agent in the treatment of hyperlipidemia.

AB - We investigated the antihyperlipidemic activity of an aqueous extract of a herbal preparation from a combination of six Indian medicinal plants. The current study was undertaken to assess the hypolipidemic, hypocholesterolemic and hypotriglyceridemic potential of the polyherbal extract using Triton WR 1339 (Tyloxapol) induced hyperlipidemia. The animals were divided into four groups'normal control, hyperlipidemic control, hyperlipidemic plus polyherbal extract and hyperlipidemic plus Lovastatin. Hyperlipidemia was induced by single intravenous injection of Triton WR 1339. Intragastric administration of polyherbal extract (500mg/kg of body weight) significantly decreased plasma cholesterol, triglyceride, non-HDL-C and phospholipids levels and increased HDL-C levels. Atherogenic index and triglyceride secretion rate were lowered in the polyherbal extract fed animals when compared to hyperlipidemic animals. Polyherbal extract exhibited quite competitive potential when compared with the reference drug Lovastatin affording a possible alternative therapeutic agent in the treatment of hyperlipidemia.

KW - Hypercholesterolemia

KW - Polyherbal

KW - Triton WR 1339

UR - http://www.scopus.com/inward/record.url?scp=77649186018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649186018&partnerID=8YFLogxK

U2 - 10.4103/0973-8258.54900

DO - 10.4103/0973-8258.54900

M3 - Article

VL - 3

SP - 119

EP - 124

JO - International Journal of Green Pharmacy

JF - International Journal of Green Pharmacy

SN - 0973-8258

IS - 2

ER -